Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Becton, Dickinson & Co. | 12 | 0 | 3 | 0 | €223.80 | €263.69 | 17.826% |
| R1 RCM Inc. | 23 | 0 | 3 | 0 | €11.80 | €17.21 | 45.869% |
| United Therapeutics | 24 | 0 | 3 | 0 | €311.90 | €300.00 | -3.815% |
| Trinity Biotech ADR | 27 | 0 | 3 | 0 | €0.41 | - | - |
| Corcept Therapeutics Inc. | 17 | 0 | 3 | 0 | €33.39 | €37.08 | 11.045% |
| Biogen Inc. | 52 | 1 | 4 | 0 | €198.85 | €291.35 | 46.515% |
| Arrowhead Pharmaceuticals Inc. | 21 | 2 | 4 | 0 | €26.67 | €54.98 | 106.153% |
| Regeneron Pharmaceuticals Inc. | 45 | 1 | 4 | 0 | €996.60 | €1,034.6 | 3.816% |
| Vertex Pharmaceuticals Inc. | 55 | 2 | 4 | 0 | €467.40 | €450.36 | -3.645% |
| Intuitive Surgical Inc | 36 | 0 | 5 | 0 | €401.70 | €396.27 | -1.351% |
| Align Technology | 20 | 2 | 5 | 0 | €214.00 | €308.48 | 44.151% |
| Centene Corp. | 23 | 0 | 5 | 0 | €71.15 | €82.57 | 16.051% |
| Neurocrine Bioscience | 36 | 0 | 5 | 0 | €130.55 | €143.34 | 9.800% |
| Illumina Inc. | 27 | 4 | 5 | 0 | €113.32 | €162.53 | 43.427% |
| Medpace Holdings Inc | 16 | 0 | 6 | 0 | €350.60 | €418.12 | 19.259% |
| Thermo Fisher Scientific Inc. | 31 | 0 | 6 | 0 | €566.20 | €576.43 | 1.806% |
| Ionis Pharmaceuticals Inc. | 26 | 5 | 6 | 0 | €46.04 | €56.86 | 23.506% |
| Johnson & Johnson | 42 | 1 | 7 | 0 | €148.62 | €187.15 | 25.927% |
| Eli Lilly Corp. | 62 | 1 | 7 | 1 | €730.10 | €824.47 | 12.925% |
| Edwards Lifesciences Corp. | 32 | 1 | 7 | 0 | €59.70 | €84.34 | 41.266% |
| Dexcom Inc. | 25 | 0 | 8 | 0 | €65.31 | €121.92 | 86.672% |
| Insmed Inc. | 42 | 0 | 8 | 0 | €68.00 | €71.14 | 4.618% |
| HCA Holdings Inc. | 38 | 0 | 9 | 0 | €334.30 | €336.94 | 0.790% |
| AbbVie Inc. | 32 | 0 | 9 | 0 | €173.68 | €180.22 | 3.765% |
| Boston Scientific | 57 | 0 | 10 | 0 | €68.50 | €76.43 | 11.574% |